August 14, 2023
UNC researchers report that the gut microbiome has a significant impact on the acquisition of Epstein-Barr virus and human immunodeficiency virus-1 infection and plays a role in the course of disease.
August 7, 2023
Researchers have divided HPV+ head and neck cancers into two distinct subtypes, which can help determine how well patients will respond to therapy.
July 11, 2023
Vance Aldrich Bell III experienced positive life-changing results after participating in a clinical trial for squamous cell carcinoma of the tongue.
July 5, 2023
A cancerous lump was discovered during Brian Stepien's annual physical. The early catch meant the tumor was still treatable.
April 15, 2023
February 21, 2023
February 20, 2023
UNC Lineberger researchers made the stunning discovery that telomeres contain genetic information to produce two small proteins, one of which they found is elevated in some human cancer cells.
February 6, 2023
A study led by researchers in the lab of Blossom Damania, PhD, shows how Kaposi sarcoma-associated herpesvirus and Epstein-Barr virus evade innate immune detection to spread undeterred.
January 30, 2023
Carla Chibwesha, MD, MSc, will collaborate with investigators in a multi-institutional project to develop trials to be conducted at clinical sites in Kenya, Uganda and Botswana.
November 18, 2022
Twelve UNC Lineberger Comprehensive Cancer Center members were named to Clarivate’s 2022 Highly Cited Researchers list.
